CSTL
Castle Biosciences Inc.
Company Overview
| Mkt Cap | $710.99M | Price | $25.50 |
| Volume | 454.26K | Change | +5.33% |
| P/E Ratio | 39.0 | Open | $24.17 |
| Revenue | $332.1M | Prev Close | $24.21 |
| Net Income | $18.2M | 52W Range | $14.59 - $35.84 |
| Div Yield | N/A | Target | $35.63 |
| Overall | 64 | Value | 65 |
| Quality | -- | Technical | 63 |
No chart data available
Stock Overview
Updated DailyCastle Biosciences Inc. (CSTL) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $25.50 with a market capitalization of $710.99 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows CSTL with a volume of 454K shares. The stock opened down 0.17% from yesterday's close of $24.21. Current analyst estimates project earnings of $-0.64 per share for this year, with next year targeting $-1.82.
CSTL demonstrates positive technical signals based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for CSTL include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 39.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 09:15 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CSTL | $25.50 | +5.3% | 454.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |